BioAv Cancer Research Results
BioAv, bioavailability: Click to Expand ⟱
| Source: |
| Type: measurement |
Bioavailability (usually in %) absorbed by the body.
|
Lung, Lung Cancer: Click to Expand ⟱
Lung CSC (Cancer Stem Cells) markers (CD133, CD44, ALDHA1, Nanog and Oct4)
|
Scientific Papers found: Click to Expand⟱
eff↑, AMPK↑, toxicity↝, BioAv↑, TRPV1↑, TumCI↓,
*BioAv↑, ROS↑, TumCD↑, TumCCA↑, MMP2↓, TumMeta↓, TumCI↓, GSH↓, eff↑,
| - |
in-vitro, |
BC, |
MCF7 |
|
|
|
- |
in-vitro, |
BC, |
4T1 |
|
|
|
- |
in-vitro, |
Lung, |
A549 |
|
|
|
- |
in-vitro, |
Liver, |
HepG2 |
|
|
|
eff↑, GSH↓, H2O2↑, ROS↑, *BioAv↑, selectivity↑, TumCCA↑, Apoptosis↑, Fenton↑, *toxicity?,
| - |
in-vitro, |
Nor, |
BEAS-2B |
|
|
|
- |
in-vitro, |
Lung, |
H1299 |
|
|
|
- |
in-vitro, |
Lung, |
H460 |
|
|
|
HSP90↓, toxicity↝, eff↑, chemoPv↑, p53 Wildtype↓, CDK4↓, MAPK↓, Hif1a↓, selectivity↑, compI↓, TumCP↓, BioAv↑,
| - |
in-vitro, |
Cerv, |
HeLa |
|
|
|
- |
in-vitro, |
Liver, |
HepG2 |
|
|
|
- |
in-vitro, |
BC, |
MCF7 |
|
|
|
- |
in-vitro, |
Lung, |
A549 |
|
|
|
- |
in-vitro, |
Nor, |
HUVECs |
|
|
|
eff↑, Dose∅, *BioAv↑, selectivity↑, TumCP↓, Casp↑, PTEN↑, TSC1↑, mTOR⇅, Akt↓, PDK1↓, E6↓, E7↓, DNAdam↑, ROS↑, *BioAv↓, *BioEnh↑, *Half-Life∅,
*cardioP↑, *Inflam↓, BioAv↑, TNF-α↓, MIP‑1α↓, GranB/GZMB↓,
BioAv↑, toxicity↝, Ki-67↓, miR-106b↓, chemoPv↑, Dose↝, miR-19b↓, PTEN↑, IGF-2R↑, p‑Akt↓, PGE2↓, PGI2↓, COX2↓, Apoptosis↑, TumCP↓, Inflam↓, cardioP↑,
| - |
in-vitro, |
Lung, |
A549 |
|
|
|
- |
in-vitro, |
Lung, |
H460 |
|
|
|
- |
in-vivo, |
NA, |
NA |
|
|
|
eff↑, BioAv↑, eff↑, PI3K↓, Akt↓,
RadioS↑, TumCD↑, ROS↑, Imm↑, angioG↓, BioAv↑, TumCP↓, Apoptosis↓, TumMeta↓,
Showing Research Papers: 1 to 9 of 9
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 9
Pathway results for Effect on Cancer / Diseased Cells:
NA, unassigned(tgid=0) ⓘ
IGF-2R↑, 1, miR-106b↓, 1, PGI2↓, 1,
Redox & Oxidative Stress(tgid=1) ⓘ
compI↓, 1, Fenton↑, 1, GSH↓, 2, H2O2↑, 1, ROS↑, 4,
Core Metabolism/Glycolysis(tgid=4) ⓘ
AMPK↑, 1, PDK1↓, 1,
Cell Death(tgid=5) ⓘ
Akt↓, 2, p‑Akt↓, 1, Apoptosis↓, 1, Apoptosis↑, 2, Casp↑, 1, GranB/GZMB↓, 1, MAPK↓, 1, TRPV1↑, 1, TumCD↑, 2,
Protein Folding & ER Stress(tgid=8) ⓘ
HSP90↓, 1,
DNA Damage & Repair(tgid=10) ⓘ
DNAdam↑, 1, p53 Wildtype↓, 1,
Cell Cycle & Senescence(tgid=11) ⓘ
CDK4↓, 1, TumCCA↑, 2,
Proliferation, Differentiation & Cell State(tgid=12) ⓘ
mTOR⇅, 1, PI3K↓, 1, PTEN↑, 2,
Migration(tgid=13) ⓘ
Ki-67↓, 1, miR-19b↓, 1, MMP2↓, 1, TSC1↑, 1, TumCI↓, 2, TumCP↓, 4, TumMeta↓, 2,
Angiogenesis & Vasculature(tgid=14) ⓘ
angioG↓, 1, Hif1a↓, 1,
Immune & Inflammatory Signaling(tgid=16) ⓘ
COX2↓, 1, Imm↑, 1, Inflam↓, 1, MIP‑1α↓, 1, PGE2↓, 1, TNF-α↓, 1,
Drug Metabolism & Resistance(tgid=21) ⓘ
BioAv↑, 6, Dose↝, 1, Dose∅, 1, eff↑, 7, RadioS↑, 1, selectivity↑, 3,
Clinical Biomarkers(tgid=22) ⓘ
E6↓, 1, E7↓, 1, Ki-67↓, 1,
Functional Outcomes(tgid=23) ⓘ
cardioP↑, 1, chemoPv↑, 2, toxicity↝, 3,
Total Targets: 54
Pathway results for Effect on Normal Cells:
Immune & Inflammatory Signaling(tgid=16) ⓘ
Inflam↓, 1,
Drug Metabolism & Resistance(tgid=21) ⓘ
BioAv↓, 1, BioAv↑, 3, BioEnh↑, 1, Half-Life∅, 1,
Functional Outcomes(tgid=23) ⓘ
cardioP↑, 1, toxicity?, 1,
Total Targets: 7
Scientific Paper Hit Count for: BioAv, bioavailability
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:15 Cells:% prod#:% Target#:792 State#:% Dir#:2
wNotes=0 sortOrder:rid,rpid
Home Page